Alovudine
Jump to navigation
Jump to search
![]() | |
Clinical data | |
---|---|
Other names | Fluorothymidine |
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13FN2O4 |
Molar mass | 244.222 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.[1]
See also
- Fluorothymidine F-18, an isotopically enriched version of alovudine used as a PET tracer
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Antiviral drugs
- Pyrimidinediones
- Organofluorides
- Abandoned drugs
- All stub articles
- Antiinfective agent stubs